|Day Low/High||21.21 / 21.49|
|52 Wk Low/High||20.28 / 35.41|
Stocks fluctuate late Tuesday as earnings reports are mixed.
Aetna and Humana each traded down sharply as antitrust hurdles may block $34 billion merger.
IMF cuts growth estimates for the U.K. by almost 1 percentage point for 2017.
A rush of earnings kept investors busy throughout the morning. Netflix was one of the biggest drags on the Nasdaq and S&P 500.
Stocks are off session lows by mid-morning Tuesday with the Dow Jones Industrial Average trying for gains after a rush of key earnings.
The chemicals giant grew revenues in every division and upped its bid for U.S.-based Monsanto this week.
A huge break fee and debt financing might convince Monsanto to open its books but the German bidder probably won't dig much deeper.
The S&P 500 closed out Thursday's session with its fourth record close in a row as hopes for global monetary stimulus kept hopes high on Wall Street.
What a week. The S&P 500 closed out Thursday's session with its fourth record close in a row as hopes for global monetary stimulus kept hopes high on Wall Street.
The S&P 500 comes off session highs by Thursday afternoon, though remains on track for a record close for the fourth time this week.
Shares in the potential German seller rise sharply, despite some suspicions the talks are a negotiating ruse by the St. Louis company.
U.K.’s June 23 referendum on its relationship with the European Union sends jitters through markets across the globe
Shell pulls up the FTSE 100 on new cost-cutting plans.
Brussels statisticians raise their estimate of first-quarter eurozone growth, while Shell promises more cost cuts following its BG purchase.
ECB president Mario Draghi said that growth in euro area will be muted for the time being.
It took some time but Wall Street eventually got used to the higher prospects for a June rate hike this week.
Marks & Spencer falls as a pretax profit slump offsets a higher dividend payment, while Bayer vows to press on with its pursuit of Monsanto.
U.S. stocks rocketed higher as the fears over rate hikes that have plagued Wall Street for nearly a week began to fade on Tuesday.
Who's afraid of the big, bad Fed? Not Wall Street. Not anymore.
Stocks rocket higher on Tuesday as the fears over rate hikes that have plagued Wall Street for nearly a week begin to fade.
Bayer says there's logic behind its $62 billion bid for the agricultural company. Analysts are not so sure.
Wall Street weighed the odds of a June rate hike, and the uncertainty left markets paralyzed for much of Monday's session.
The Federal Reserve remains in focus on Monday with speculation over a June rate hike leading to choppy trading.
The FTSE 100 falls as the U.K. Treasury issues a recession warning on the upcoming ‘Brexit’ referendum.
German company Bayer offers a 37% premium to its St. Louis target's undisturbed share price.
Stocks struggle for direction on Monday morning as the possibility of a rate hike in June continues to loom large over Wall Street.
There's no way Bayer's potential takeover of Monsanto can survive heightened government opposition to deals perceived as curbing competition, says TheStreet's Jim Cramer.
Stock futures are narrowly mixed on Monday morning as the possibility of a June rate hike looms large over Wall Street.
U.S. stock futures are rising slightly on Monday while European stocks trade mixed as data points to further evidence of subdued growth in the eurozone.
Bayer declines as it confirms a rights issue is on the agenda if a $62 billion takeover run at Monsanto succeeds.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.